Browsing eNauka
Browsing by Author Selmaj, Krzysztof
Showing results 1 to 13 of 13
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2008 | Cerebrospinal fluid cell phenotypic analysis from a phase 2 trial of the BHT-3009 DNA vaccine for multiple sclerosis | Nadj, Congor G; Nadj, Ilinka; Havrdova, Eva; Krasulova, Eva; Selmaj, Krzysztof; Losy, Jacek; Radue, Ernst-Wilhelm; Gianettoni, Jill; Solvason, Nanette; Tersini, Karen;
Valone, Frank; Utz, Paul J; Robinson, William H; Steinman, Lawrence; Garren, Hideki;
| Conference Paper | Mp. category will be shown later |
| 2015 | Correlation of brain volume and physical measures with cognitive function using baseline data from the anti-LINGO-1 SYNERGY trial in multiple sclerosis | Cadaviv, Diego; Hupperts, Raymond; Drulović, Jelena S.  ; Selmaj, Krzysztof; Montalban, Xavier; Kostić, Smiljana  ; Valis, Martin; Evdoshenko, E.; Zhang, Yiwei; Xu, Lei;
Mellion, Michelle;
| Conference Paper | Mp. category will be shown later |
| 2017 | Correlation of brain volume and physical measures with cognitive function using baseline data from the anti-LINGO-1 SYNERGY trial in multiple sclerosis | Hupperts, Raymond; Drulović, Jelena ; Selmaj, Krzysztof; Montalban, Xavier; Kostić, Smiljana ; Valis, Martin; Zhang, Yiwei; Xu, Lei; Mellion, Michelle; Cadaviv, Diego | Conference Paper | Mp. category will be shown later |
| 2016 | Correlation of Brain Volume and Physical Measures with Cognitive Function Using Baseline Data from the Anti-LINGO-1 SYNERGY Trial in Multiple Sclerosis | Hupperts, Raymond; Drulović, Jelena S. ; Selmaj, Krzysztof; Montalban, Xavier; Kostić, Smiljana ; Valis, Martin; Evdoshenko, Evgeniy; Zhang, Yiwei; Xu, Lei; Mellion, Michelle;
Cadavid, Diego;
| Conference Paper | Mp. category will be shown later |
| 2016 | Correlation of Physical, Cognitive and MRI Measures with Multifocal Visual Evoked Potential using Baseline Data from the Anti-LINGO-1 SYNERGY Trial in Multiple Sclerosis | Cadavid, Diego; Klistorner, Alexander; Ampapa, Radek; Bonek, Robert; Drulović, Jelena S. ; Kostić, Smiljana ; Maciejowski, Maciej; Selmaj, Krzysztof; Valis, Martin; Zielinski, Tomasz;
Ibrahim, Adama; Zhang, Yiwei; Xu, Lei;
| Conference Paper | Mp. category will be shown later |
| 2022 | Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: final safety and efficacy results from the phase 3 EVOLVE-MS-1 study | Singer, Barry A.; Drulović, Jelena S. ; Negroski, Donald; Selmaj, Krzysztof; Bergh, Florian Then; Scaramozza, Matthew; Castro-Borrero, Wanda; Adair, Hannah; Chen, Hailu; Levin, Seth;
Shankar, Sai L.; Wray, Sibyl;
| Conference Paper | Mp. category will be shown later |
| 2012 | Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study | Arnold, Douglas L; Brinar, Vesna; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Fisher, Elizabeth; Fox, Edward; Giovannoni, Gavin; Hartung, Hans; Havrdova, Eva;
Selmaj, Krzysztof; Weiner, Howard; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |
| 2012 | Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients | Coles, Alasdair; Brinar, Vesna; Arnold, Douglas L; Cohen, Jeffrey; Confavreux, Christian; Fox, Edward; Hartung, Hans; Havrdova, Eva; Selmaj, Krzysztof; Weiner, Howard;
Giovannoni, Gavin; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |
| 2012 | Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I) | Havrdova, Eva; Arnold, Douglas L; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Fox, Edward; Hartung, Hans; Selmaj, Krzysztof; Weiner, Howard; Brinar, Vesna;
Giovannoni, Gavin; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Oyuela, Pedro; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |
| 2008 | Phase 2 follow-up results of the BHT-3009 DNA vaccine for multiple sclerosis | Havrdova, Eva; Krasulova, Eva; Nadj, Congor G; Selmaj, Krzysztof; Losy, Jacek; Nadj, Ilinka; Radue, Ernst-Wilhelm; Gianettoni, Jill; Valone, Frank; Utz, Paul J;
Robinson, William H; Steinman, Lawrence; Garren, Hideki;
| Conference Paper | Mp. category will be shown later |
| 2008 | Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis | Garren, Hideki; Robinson, William H; Krasulova, Eva; Havrdova, Eva; Nadj, Congor G; Selmaj, Krzysztof; Losy, Jacek; Nadj, Ilinka; Radue, Ernst-Wilhelm; Kidd, Brian A;
Gianettoni, Jill; Tersini, Karen; Utz, Paul J; Valone, Frank; Steinman, Lawrence;
| Article | 21a+M21a+ |
| 2007 | Phase IIb trial of a MBP encoding DNA plasmid (BHT-3009) for the treatment of relapsing-remitting multiple sclerosis | Garren, Hideki; Krasulova, Eva; Havrdova, Eva; Nadj, Congor G; Nadj, Ilinka; Selmaj, Krzysztof; Radue, Ernst-Wilhelm; Gianettoni, Jill; Tersini, Karen; Valone, Frank;
Robinson, William H; Utz, Paul J; Steinman, Lawrence;
| Conference Paper | Mp. category will be shown later |
| 2012 | Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints | Fox, Edward; Arnold, Douglas L; Brinar, Vesna; Cohen, Jeffrey; Coles, Alasdair; Confavreux, Christian; Giovannoni, Gavin; Hartung, Hans; Havrdova, Eva; Selmaj, Krzysztof;
Stojanovic, Miroslav; Weiner, Howard; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
| Conference Paper | Mp. category will be shown later |